News
-
-
PRESS RELEASE
Bone Health Technologies Secures $5 Million in Funding to Transform Osteopenia Care
Bone Health Technologies (BHT) closes oversubscribed $5 million financing round with new investors, including Terumo Medical, to advance Osteoboost wearable vibration device for postmenopausal women's bone health -
PRESS RELEASE
Bone Health Technologies Announces FDA Clearance of OsteoboostTM, the First Prescription Medical Device to Treat Low Bone Density
Bone Health Technologies announces FDA clearance for Osteoboost, a non-pharmacological prescription treatment for postmenopausal women with osteopenia. Osteoboost is a wearable device that delivers targeted vibration to the lumbar spine and hips to reduce bone strength and density decline. This breakthrough technology is safe, medication-free, and has shown efficacy in reducing bone strength loss. The clearance represents a significant advancement in the treatment of low bone density, addressing an underserved need in women's health.
-
Revolutionizing Fire Camps: NUE's Sustainable Power Solutions Shine at USDA Technology & Development Center
-
Save A Train Continues to Innovate with Rail Enrichment
-
Cameron Ashley Building Products Opens Third Location in the Badger State
-
Event Tickets Center is Named Official Secondary Ticketing Reseller Partner for Most Valuable Promotions and the Historic Jake Paul vs. Mike Tyson Fight
-
GRI Bio (NASDAQ: GRI) Participates in Virtual Investor CEO Connect
-
Amendment of the terms and conditions of the bond completed; Bondholders can convert bonds into shares
-
secunet Security Networks AG successfully holds Annual General Meeting – Broad approval for all proposed resolutions
-
TUI AG: Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
-
Fuller, Smith & Turner PLC: Transaction in own shares
-
AngloGold Ashanti US$9.0m (A$13.5m) Gold Farm-in Agreement
-
2024 Annual General Meeting: approval of all resolutions submitted to the Meeting
-
PR – ICADE – Success of the cash tender offer for a total amount of €350 million
-
AMOEBA: ORDINARY AND EXTRAORDINARY GENERAL MEETING OF 27 JUNE 2024 - Availability of preliminary documents
-
Availability of preparatory documents for the annual general meeting of June 13, 2024
-
Safran’s 2024 Annual General Meeting